Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-06-03
2009-06-30
Clow, Lori A (Department: 1631)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07553809
ABSTRACT:
This invention relates to a method of inhibiting Fc receptor binding of immunoglobulin including the use of a Fc receptor modulating compound which binds to defined surfaces on a Fc receptor. The present invention also relates to a method for treating a variety of diseases using a Fc receptor modulating compound.
REFERENCES:
patent: 4686282 (1987-08-01), Hahn
patent: 4752601 (1988-06-01), Hahn
patent: 5824487 (1998-10-01), Ravetch et al.
patent: 6503509 (2003-01-01), Vilen et al.
patent: 6835753 (2004-12-01), Baell et al.
patent: 750960 (1982-04-01), None
patent: WO 86/01211 (1986-02-01), None
patent: WO 95/28959 (1995-11-01), None
patent: WO 96/08512 (1996-03-01), None
patent: WO 97/40033 (1997-10-01), None
patent: WO 99/40117 (1999-08-01), None
Burmeister et al.,Nature, 372:379-383 (1994).
Burmeister et al.,Nature, 372:336-343 (1994).
Chemical Abstracts CA:55:1138e (1955).
Garman et al.,Cell, 95:951-961 (1998).
Holm et al.,Nucleic Acids Research, 26(1):316-319 (1998).
Holm et al.,Science, 273:595-602 (1996).
Holm et al.,J. Mol. Biol., 233:123-138 (1993).
Huang et al.,Biopolymers, 43(5):367-382 (1997).
Huber et al.,J. Mol. Biol., 230:1077-1088 (1993).
Hulett et al.,Advances in Immunology, 57:1-127 (1994).
Knegtel et al.,J. Mol. Biol., 266:424-440 (1996).
Kwack et al., “Functional Consequences of the Interaction Between T-cell Antigen Receptors and FcyRs on T Cells”, Immunology Letters, 44 (1995) pp. 139-143, Elsevier Science B.V.
Maxwell et al.,Nature Structural Biology, 6(5):437-442 (1999).
McKenzie et al., “The Role of Human Fc Receptor FcyRIIA in the Immune Clearance of Platelets: A Transgenic Mouse Model”,J. Immunology, pp. 4311-4318.
Murali et al.,Immunologic Research, 17(1&2):163-169 (1998).
Padlan et al.,Receptor, 2:129-144 (1992).
Padlan et al.,Biochemical Society Transactions, 21:963-967 (1993).
Protein Data Bank Accession No. 1ALT (Summary).
Russell et al.,J. Mol. Biol., 244:332-350 (1994).
Tabata et al., Pharm. Res. (1993), 10(4), 487-96 (abstract).
Weng et al.,J. Mol. Biol., 282:217-225 (1998).
Williams et al., “The Immunoglobulin Superfamily—Domains for Cell Surface Recognition,” pp. 381-405 (1988).
Baell Jonathan B.
Epa Vidana
Garrett Thomas P. J.
Hogarth P. Mark
Matthews Barry R.
Clow Lori A
Ilexus Pty Limited
Skibinsky Anna
LandOfFree
Fc receptor modulators and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fc receptor modulators and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fc receptor modulators and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4101033